In this episode of Beatwise The Podcast, I sit down with leading cardiologist and clinical researcher Dr. Louise Segan to explore a groundbreaking question: Can patients with heart failure actually recover heart function through targeted treatment of atrial fibrillation (AF)?
We dive into the fascinating findings of the Withdraw HF study, which investigates heart failure patients with atrial fibrillation and examines whether their heart function can improve enough to reduce - or even withdraw - heart failure medication. Dr. Segan shares insights into personalized treatment strategies, the role of rhythm control in AF-mediated cardiomyopathy, and what this could mean for the future of heart failure care.
Whether you're a clinician, a researcher, or someone personally impacted by AF or heart failure, this episode offers cutting-edge research and practical takeaways that could reshape how we think about heart recovery.
EPISODE HIGHLIGHTS:
[0:00] - Welcome to Beatwise: Introducing the episode and guest, Dr. Louise Segan
[1:09] - What is atrial fibrillation and how does it relate to heart failure?
[5:08] - Understanding AF-mediated cardiomyopathy and its management challenges
[8:59] - Inside the Withdraw HF study: why it was launched and how it was designed
[14:10] - What the results reveal about heart function recovery and medication withdrawal
[23:50] - Why ongoing monitoring and individualized care are essential for long-term success
[29:17] - Final thoughts on the future of personalized heart failure treatment
If you enjoyed this episode, please like, rate, and subscribe to Beatwise The Podcast. Your support helps me reach more listeners and continue providing valuable content.
Don't forget to follow me on social media @sarah.theheartdoc for the latest updates, behind-the-scenes content, and more engaging discussions. Stay connected and be part of our growing community!
","author_name":"Sarah Birkhoelzer"}